From Hellmann's to Gummies: Unilever's $1.2B Grüns Acquisition Is the Clearest Signal FMCG Capital Has Left Food

The same company that agreed to sell Hellmann's, Knorr, and roughly 150 years of food heritage for $42.7 billion to McCormick on March 31, 2026, returned to the dealmaking table five days later — and paid $1.2 billion for a gummy supplement brand that did not exist three years ago.

That is not a contradiction. It is a strategy.

The Grüns Deal, in Numbers

Grüns was founded in August 2023 by Chad Janis with a single idea: make daily greens supplementation enjoyable enough that people actually do it. Within two years, the brand exceeded $300 million in annual revenue, shipped 10 million gummies per day, and became the number-one greens supplement on Amazon and in U.S. retail. When Unilever's acquisition closes later in 2026, it will have paid approximately four times trailing revenues — a multiple that reflects not just current performance, but strategic optionality in a category that traditional FMCG has barely touched.

The deal was confirmed on April 4 and announced publicly on April 9. Unilever CEO Hein Schumacher described Grüns as "one of the fastest-growing health and wellbeing businesses in the United States," adding that its distribution architecture — direct-to-consumer, Amazon, Sprouts, Target, Walmart, and Costco — represents the modern multi-channel model that legacy food brands have spent billions trying to replicate.

Why Wellness, Why Now

The U.S. supplement market was valued at $69 billion in 2024 and is projected to reach $87 billion by 2028 — a category growing at roughly twice the rate of conventional packaged food. Within that, greens supplements, functional gummies, and condition-specific VMS (vitamins, minerals, and supplements) products are the fastest-growing segment, driven by three structural tailwinds: rising health consciousness, an aging consumer base, and the GLP-1 effect.

That last factor is the one most industry leaders are underestimating. Consumers on GLP-1 medications — Ozempic, Wegovy, and their successors — eat significantly less. But reduced caloric intake creates documented micronutrient deficiencies. The most commercially logical response is a high-frequency, enjoyable, daily supplement product. Grüns sits precisely in that intersection.

Unilever is not alone in reading this signal. Nestlé has flagged its medical and active nutrition segment as a core priority under its restructuring plan, even as it exits water and coffee brands. PepsiCo acquired Siete Foods and Poppi — both built on functional-food positioning — for a combined $3.15 billion. The direction of capital in FMCG is unmistakable.

The DTC-to-Retail Playbook as a Valuation Event

What separates Grüns from the hundreds of wellness brands competing in the same category is its distribution trajectory. The company launched direct-to-consumer in August 2023, built Amazon dominance within months, and within two years secured shelf space at Sprouts, Target, Walmart, and Costco — four retailers representing entirely different consumer demographics and purchasing occasions. That distribution stack, not the product itself, is what justified the $1.2 billion exit price.

This is the modern CPG acquisition template: build DTC to prove the consumer proposition, use Amazon to scale at lower customer acquisition cost, then convert that data into retail placement negotiations. By the time a strategic acquirer arrives, the brand is not a startup — it is a shelf-optimised, multi-channel business with three years of consumer repeat purchase data. Unilever is not buying a bet. It is acquiring a proven model.

What This Means for the Competitive Landscape

Unilever now holds a portfolio anchored in functional health, personal care, and prestige beauty — not food. The $15.7 billion in cash proceeds from the McCormick deal give it significant acquisition optionality through 2027. With a declared wellness mandate and substantial capital, Unilever will remain the most active strategic acquirer in the VMS and functional health space for the next 18 months.

The contrast with food is not accidental. Hellmann's and Knorr — brands with 100-plus year histories and billions in annual revenue — were sold at $42.7 billion enterprise value. Grüns — three years old, $300 million in revenue — was acquired for $1.2 billion. On a revenue multiple basis, Grüns commanded approximately 4x trailing revenue; legacy food assets in the McCormick deal implied roughly 2.5x. Capital markets are paying a growth premium for wellness that conventional food simply cannot command.

For operators, investors, and strategic buyers in food and beverage: the question is no longer whether wellness is a strategic priority. It is whether you are building, buying, or being left behind.